All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, February 4, 2023
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Dxcover - CEO - Mark Hegerty

Dxcover reveals $12M in new funding for multi-cancer early detection platform

Feb. 3, 2023
By Annette Boyle
No Comments
Dxcover Ltd. raised $9.25 million (£7.5 million) in a series A fundraising round and received a grant of $2.7 million (£2.2 million) from the European Innovation Council to support development of the company’s liquid biopsy platform for the detection of multiple early-stage cancers. Existing investors Eos Advisory LLP, Mercia Asset Management plc, Scottish Enterprise, University of Strathclyde, SIS Ventures and Norcliffe Capital led the round, which was also joined by Mark Banforth of Thairm Bio.
Read More

Biopharma financings hit $3.9B in January, down by 22% from last year

Feb. 3, 2023
By Karen Carey
No Comments
Starting out the year slow, biopharma financings are about 22% below where they were at the end of January last year, and they are well behind the first month of the previous two years as well, suggesting company executives may need to continue to prioritize costly programs as resources are depleted – at least for the near future.
Read More

Financings for Feb. 3, 2023

Feb. 3, 2023
No Comments
Biopharmas raising money in public or private financings, including: Avalo, Cellectis, Ensysce, Kiora, Paxmedica, Provention, Roivant, Structure, Tenax.
Read More

Financings for Feb. 2, 2023

Feb. 2, 2023
No Comments
Biopharmas raising money in public or private financings, including: Mineralys, Roivant, Vera.
Read More
Tumor microenvironment
Cancer

TVM Capital invests in Recurv Pharma to advance novel taxane RP-001

Feb. 2, 2023
No Comments
Recurv Pharma Inc. is set to receive investment of up to $24 million from TVM Capital Life Science GmbH to support development up to phase IIa proof of concept of RP-001 to treat solid tumors.
Read More

Financings for Feb. 1, 2023

Feb. 1, 2023
No Comments
Med-tech firms raising money in public or private financings, including: Aluna, Dxcover, Genedx, Ronovo, Sharps Technology.
Read More

Financings for Feb. 1, 2023

Feb. 1, 2023
No Comments
Biopharmas raising money in public or private financings, including: AB, Avenue, Cytomed, Ratio, Recurv, Resolutionrx, Respirex and Sol-Gel.
Read More

Financings for Jan. 31, 2023

Jan. 31, 2023
No Comments
Biopharmas in Asia-Pacific raising money in public or private financings: Asahi Kasei, Biolife Solution, Bristol Myers Squibb, Charles River, Harbour Biomed, HBM Alpha, Iaso, Ivexsol, Kazia.
Read More

Financings for Jan. 31, 2023

Jan. 31, 2023
No Comments
Biopharmas raising money in public or private financings, including: Nfl.
Read More

Financings for Jan. 30, 2023

Jan. 30, 2023
No Comments
Biopharmas raising money in public or private financings, including: Alto, Avenue, Inhibikase, Pliant, Precigen, Ribon, Structure, Summit.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 360 361 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld
    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 3, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Feb. 3, 2022.
  • Setpoint Medical - vagus nerve stimulation device

    Setpoint Medical lands up to $145M to advance RA implant

    BioWorld MedTech
    Bioelectronic medicine startup Setpoint Medical Corp. raised $80 million in a preferred stock financing co-led by new investors Norwest Venture Partners and...
  • CFIUS singles out mergers with Chinese companies as potential national security threats

    BioWorld
    Proposed mergers with Chinese companies will likely be subject to increased scrutiny from the Committee on Foreign Investment in the United States (CFIUS) as...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing